NEW YORK (GenomeWeb) – Sophia Genetics and Genycell Biotech today announced a partnership to expand access to the Sophia Data Driven Medicine (Sophia DDM) platform. 

As part of the deal, Genycell will distribute Sophia DDM as part of a package to laboratories and hospitals in Spain and Portugal performing next-generation sequencing-based clinical diagnosis, a Sophia spokesman said. Sophia DDM uses machine learning and algorithms for genomic analysis of patient samples. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.